• to lower the chance of severe cardiovascular (coronary heart and blood vessel) difficulties in Older people with variety two diabetes and heart problemsCalifornia biotech behemoth Amgen ditched plans for an experimental weight loss capsule in May but is still hoping for just a slice of the market with MariTide, a monthly injection that is certa